Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nrx Pharmaceuticals Inc (NQ: NRXP )

0.5346 -0.0424 (-7.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,985,103
Open 0.5800
Bid (Size) 0.5325 (3)
Ask (Size) 0.5400 (68)
Prev. Close 0.5770
Today's Range 0.5110 - 0.5801
52wk Range 0.4899 - 26.24
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
88 Biggest Movers From Yesterday
Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit. 
Via Benzinga
Earnings Scheduled For May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. 
Via Benzinga

Performance

YTD
-89.24%
-89.24%
1 Month
-65.51%
-65.51%
3 Month
-82.12%
-82.12%
6 Month
-93.40%
-93.40%
1 Year
-97.57%
-97.57%

More News

Read More
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Mid-Afternoon Market Update: Dow Surges 575 Points; Apyx Medical Shares Spike Higher
Via Benzinga
Why Is NRx Pharmaceuticals (NRXP) Stock Down 60% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Mid-Day Market Update: Crude Oil Jumps Over 3%; NRx Pharmaceuticals Shares Tumble
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
61 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
The Daily Biotech Pulse: Setback For NRx Pharma's COVID Study, Fast Track Tag For Pfizer's NASH Combo Therapy, Reata's Ataxia Drug In FDA Review
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why NRX Pharmaceuticals Shares Are Trading Lower During Premarket On Thursday?
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
20 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
NASDAQ:NRXP Long Term Investor Alert: Investigation over Possible Wrongdoing at NRx Pharmaceuticals, Inc.
Via SBWire
NRX PHARMACEUTICALS INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of NRx Pharmaceuticals, Inc. - NRXP
From Kahn Swick & Foti, LLC
Via Business Wire
NRX PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of NRx Pharmaceuticals, Inc. - NRXP
From Kahn Swick & Foti, LLC
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
NRx Pharmaceuticals Again Requests For FDA Breakthrough Therapy Status For COVID-19 Therapy
Via Benzinga
NRX PHARMACEUTICALS INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of NRx Pharmaceuticals, Inc. - NRXP
From Kahn Swick & Foti, LLC
Via Business Wire
53 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
NRx Pharma Says I-SPY Study Of Inhaled Zyesami In Critical COVID-19 Stopped
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.